15. Factors related to the treatment outcomes in patients with infective endocarditis
Main Article Content
Abstract
This retrospective study of 84 patients with infective endocarditis (IE) at the Cardiovascular Center of E Hospital from 2019 to 2024 was conducted to describe the treatment outcomes and factors related to the treatment outcomes in these patients. The results showed that, 82.1% of patients were initially treated with a combination of 2 antibiotics; 88.1% were treated with a combination of medical and surgical treatment. At the time of discharge, 94% had good progression and 6% had severe progression. Patients receiving combined medical-surgical treatment had a higher rate of good progression than patients receiving medical treatment alone (97.3% vs 70%; p < 0.05); patients treated with a combination of 2 antibiotics had higher rate of good progression than the single antibiotic treatment (97.1% vs 80.0%; p < 0.05). The rate of cerebral hemorrhage and high procalcitonin levels were significantly higher in the group with severe progression compared to the group with good progression. In conclusion, cerebral hemorrhage, high PCT levels are associated with severe progression, combined medical-surgical treatment and initial combination of antibiotic are associated with good progression in patients with IE.
Article Details
Keywords
Infective endocarditis, good progression, severe progression
References
2. Iung B, Duval X. Infective endocarditis: innovations in the management of an old disease. Nat Rev Cardiol. 2019; 16(10): 623-635. doi:10.1038/s41569-019-0215-0.
3. Phạm Mạnh Hùng, Phạm Thái Sơn, Nguyễn Ngọc Quang và cộng sự. Diễn biến tử vong và các yếu tố tiên lượng bệnh viêm nội tâm mạc nhiễm khuẩn. Tạp chí Tim mạch học Việt Nam. 2002; (29):40-45.
4. Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015; 36(44): 3075-3128. doi:10.1093/eurheartj/ehv319.
5. Cimmino G, Bottino R, Formisano T, et al. Current Views on Infective Endocarditis: Changing Epidemiology, Improving Diagnostic Tools and Centering the Patient for Up-to-Date Management. Life. 2023; 13(2): 377. doi:10.3390/life13020377.
6. Chiến ĐV, Dũng N, Hiếu LM. Tổng kết một số kinh nghiệm chẩn đoán và điều trị viêm nội tâm mạc nhiễm khuẩn tại Khoa Nội Tim mạch, Bệnh viện Trung ương Quân đội 108 giai đoạn 2015-2020. J 108 - Clin Med Phamarcy. Published online December 6, 2021. doi:10.52389/ydls.v16i7.886.
7. Nguyễn Ngọc Trang. Tỷ lệ tử vong và các yếu tố liên quan tiên lượng ở bệnh nhân Viêm nội tâm mạc nhiễm khuẩn. Published online 2021.
8. Ma L, Ge Y, Ma H, Zhu B, Miao Q. Infective endocarditis at a tertiary-care hospital in China. J Cardiothorac Surg. 2020; 15(1): 135. doi:10.1186/s13019-020-01183-2.
9. Marques A, Cruz I, Caldeira D, et al. Risk Factors for In-Hospital Mortality in Infective Endocarditis. Arq Bras Cardiol. 2020; 114(1): 1-8. doi:10.36660/abc.20180194.
10. Hoàng NN, Duy TC, Sỹ HV. Mối liên quan giữa đặc điểm vi sinh và kết quả điều trị ở bệnh nhân viêm nội tâm mạc nhiễm trùng. Tạp chí Tim mạch học Việt Nam. 2019; (88): 61-68.
11. Habib G, Erba PA, Iung B, et al. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. Eur Heart J. 2019; 40(39): 3222-3232. doi:10.1093/eurheartj/ehz620.